Axona has been investigated in clinical studies

Axona enhanced memories and cognition in a clinical study*1,2

Axona has been investigated in a clinical study of 152 people with mild to moderate Alzheimer’s disease. In this study, participants were able to remain on a normal diet and continued taking their existing treatments. Axona is simple to add, and most side effects can be managed by following some basic administration instructions.

Some people who took Axona showed better cognitive performance than those taking placebo. A number of them even saw an improvement.

Clinical results in people taking Axona1

Number of people who showed clinically meaningful improvement
Icon showing number of patients who showed clinically meaningful improvement
Number of people who showed modest improvement
Icon showing number of patients who showed modest improvement
Number of people who showed no meaningful change
Icon showing number of patients who showed modest improvement

Measuring success1,3

Successful therapy in Alzheimer’s disease can mean many different things; remaining the same or declining more slowly may represent success for some people.

Success with Axona

In the Axona clinical study, cognition in many people either:

  • Showed a modest improvement
  • Remained the same (for example, they did not get worse)
  • Declined more slowly compared with people who took placebo

Axona can be taken early – as soon as Alzheimer’s has been diagnosed1,2

With a progressive disease like Alzheimer’s, where brain cells continue to die over time, it’s good to know that Axona can be taken as soon as the disease has been diagnosed. Also, the Axona clinical study showed that as the level of ketone bodies increased, so did performance in tests of cognition. In fact, those who took Axona more than 80% of the time saw the biggest improvements. When they stopped taking Axona they began to decline.*

Many people taking Axona experienced encouraging results.1
How to take Axona